Beta Bionics, Inc. (BBNX) Earnings History
Net Loss4 years of earnings data (2022–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Beta Bionics, Inc. (BBNX) Earnings Overview
As of June 30, 2026, Beta Bionics, Inc. (BBNX) reported trailing twelve-month net income of -$66M, reflecting +79.0% year-over-year growth. The company earned $-1.50 per diluted share over the past four quarters, with a net profit margin of -73.0%.
Looking at the long-term picture, BBNX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$44M in fiscal 2023.
Beta Bionics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including TNDM (-$95M net income, -20.2% margin), PODD ($303M net income, 9.1% margin), DXCM ($930M net income, 17.9% margin), BBNX has room to improve margins relative to the peer group. Compare BBNX vs TNDM →
BBNX Earnings vs Peers
Earnings metrics vs comparable public companies
BBNX Historical Earnings Data (2022–2025)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$73M | -33.7% | -$72M | $-1.81 | -73.0% | -71.5% |
| 2024 | -$55M | -24.2% | -$45M | $-8.60 | -84.1% | -69.5% |
| 2023 | -$44M | +31.9% | -$36M | $-8.31 | -367.6% | -298.9% |
| 2022 | -$65M | - | -$66M | $-12.96 | -36173.7% | -36784.4% |
Download Data
Export BBNX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
4+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BBNX — Frequently Asked Questions
Quick answers to the most common questions about buying BBNX stock.
What is BBNX earnings per share (EPS)?
BBNX trailing twelve-month (TTM) diluted EPS is $-1.50, reflecting +79.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2022 to 2025 is available in the table on this page.
What is Beta Bionics, Inc.'s net income?
Beta Bionics, Inc. (BBNX) trailing twelve-month net income is $-66M as of 2025. Earnings grew +79.0% year-over-year.
Is BBNX profitable?
BBNX is not currently profitable on a TTM basis, reporting a net loss of $-66M. Net margin is -73.0%. Investors should monitor for a return to profitability.
What is BBNX's earnings growth rate?
BBNX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2022 to 2025.
What are BBNX's profit margins?
Beta Bionics, Inc. net profit margin is -73.0%, operating margin is -71.5%, and gross margin is +55.4%. Below-average margins reflect competitive or cost pressures. Return on Equity is -40.3%.
Is BBNX growing earnings?
Yes, BBNX earnings are accelerating — EPS growth of +79.0% exceeds the 5-year CAGR of N/A. TTM net income reached $-66M. Earnings momentum is strengthening.
What was BBNX's best earnings year?
Beta Bionics, Inc.'s highest annual net income on record is $-44M, achieved in fiscal year 2023. Earnings history on this page spans 2022 to 2025 and includes all annual and quarterly figures.
What were BBNX's earnings last quarter?
BBNX's most recent reported quarter was Q1 2026. Net income was $-22M with diluted EPS of $-0.49. For a full breakdown of all quarters, see the quarterly earnings table on this page.